Tue, April 27, 2021
Mon, April 26, 2021
Sun, April 25, 2021
Fri, April 23, 2021
Thu, April 22, 2021
Wed, April 21, 2021
Tue, April 20, 2021
Mon, April 19, 2021
Fri, April 16, 2021

David Lewis Maintained (ABT) at Buy with Increased Target to $140 on, Apr 21st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-140-on-apr-21st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $136 to $140 on, Apr 21st, 2021.

David has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • James Mainwaring of "Atlantic Equities" Initiated at Hold and Held Target at $122 on, Thursday, April 15th, 2021
  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $115 on, Saturday, February 6th, 2021


These are the ratings of the 6 analyists that currently disagree with David


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $130 on, Thursday, March 11th, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy with Increased Target to $145 on, Thursday, January 28th, 2021
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $140 on, Thursday, January 28th, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $137 on, Thursday, January 28th, 2021
  • Marie Thibault of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $140 on, Thursday, January 28th, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Thursday, January 28th, 2021

Publication Contributing Sources